文献速递头颈外科

中性粒细胞与淋巴细胞比值在头颈癌预后中的系统评价与荟萃分析

Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis.
PubMed 文献 · Head Neck · 2018-01-22

该系统评价与荟萃分析纳入24项研究共6479例头颈鳞癌患者,评估治疗前中性粒细胞与淋巴细胞比值(NLR)对总生存期(OS)的影响。

要点

  • 治疗前NLR升高是头颈鳞癌患者OS较差的预测因素,合并HR为1.78。
  • NLR升高对口腔、鼻咽、喉及下咽癌的OS均有显著负面影响。
  • NLR阈值在纳入研究中范围为2.04-5,临床解读需结合具体检测条件。

核心结论

  • 治疗前中性粒细胞与淋巴细胞比值(NLR)升高可预测头颈鳞状细胞癌(HNSCC)患者总生存期(OS)较差。

研究设计与样本

  • 系统评价与荟萃分析,通过多个数据库检索评估NLR对HNSCC患者OS影响的研究,最终纳入24篇文献共6479例患者,采用逆方差随机效应模型分析数据。

关键数值与推荐

  • NLR升高的判定阈值在纳入研究中范围为2.04-5。

临床怎么用

  • 治疗前NLR可作为HNSCC患者预后风险评估的参考指标,尤其对于下咽癌患者关联更强。
  • 临床解读NLR时应结合各研究采用的阈值范围(2.04-5),注意不同检测条件可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hematologic markers, such as the neutrophil-to-lymphocyte ratio (NLR), characterize the inflammatory response to cancer and are associated with poorer survival in various malignancies. We evaluate the effect of pretreatment NLR on overall survival (OS) in patients with head and neck squamous cell carcinoma (HNSCC). METHODS: Using multiple databases, a systematic search for articles evaluating the effect of NLR on OS in patients with HNSCC was performed. An inverse variation, random-effects model was used to analyze the data. RESULTS: A total of 24 of 241 articles, including 6479 patients, were analyzed. The combined hazard ratio for OS in patients with an elevated NLR (range 2.04-5) was 1.78 (confidence interval [CI] 1.53-2.07; P < .0001). The hazard ratios for site-specific cancer: oral cavity 1.56 CI 1.23-1.98 (P < .001), nasopharynx 1.66 CI 1.35-2.04 (P < .001), larynx 1.55 CI 1.26-1.92 (P < .001), and hypopharynx 2.36 CI 1.54-3.61 (P < .001). CONCLUSION: An elevated NLR is predictive of poorer OS in patients with HNSCC.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Mascarella MA, Mannard E, Silva SD, et al. Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis. Head Neck. 2018. PMID: 29356179. doi:10.1002/hed.25075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。